Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) EPS (Weighted Average and Diluted) (2020 - 2025)

Historic EPS (Weighted Average and Diluted) for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $0.06.

  • IceCure Medical's EPS (Weighted Average and Diluted) fell 2746.33% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.06, marking a year-over-year decrease of 2746.33%. This contributed to the annual value of $0.31 for FY2024, which is 359.06% down from last year.
  • According to the latest figures from Q3 2025, IceCure Medical's EPS (Weighted Average and Diluted) is $0.06, which was down 2746.33% from $28208.3 recorded in Q2 2025.
  • Over the past 5 years, IceCure Medical's EPS (Weighted Average and Diluted) peaked at $28208.3 during Q2 2025, and registered a low of -$0.8 during Q4 2022.
  • Its 5-year average for EPS (Weighted Average and Diluted) is $2698.2, with a median of $0.09 in 2024.
  • Per our database at Business Quant, IceCure Medical's EPS (Weighted Average and Diluted) crashed by 3962.64% in 2022 and then skyrocketed by 2577657325.1% in 2024.
  • Over the past 5 years, IceCure Medical's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.57 in 2021, then plummeted by 39.63% to -$0.8 in 2022, then skyrocketed by 109.37% to $0.07 in 2023, then increased by 18.86% to $0.09 in 2024, then dropped by 28.79% to $0.06 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.06 for Q3 2025, versus $28208.3 for Q2 2025 and $0.06 for Q1 2025.